The global macular degeneration treatment market size was valued at USD 10.06 billion in 2024 and it is projected to reach ...

Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) announced today that the Therapeutic Goods Administration (TGA) has approved SYFOVRE® (pegcetacoplan) for the every-other-month treatment of adult patients ...

Photographs taken of the retina at the back of the eye can give an indication of brain health, and by using AI software to analyse the information, scientists may be able to spot signs of disease ...